1. Home
  2. NAMSW vs CCCS Comparison

NAMSW vs CCCS Comparison

Compare NAMSW & CCCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMSW
  • CCCS
  • Stock Information
  • Founded
  • NAMSW N/A
  • CCCS 1980
  • Country
  • NAMSW Netherlands
  • CCCS United States
  • Employees
  • NAMSW 29
  • CCCS N/A
  • Industry
  • NAMSW Biotechnology: Pharmaceutical Preparations
  • CCCS Computer Software: Prepackaged Software
  • Sector
  • NAMSW Health Care
  • CCCS Technology
  • Exchange
  • NAMSW Nasdaq
  • CCCS Nasdaq
  • Market Cap
  • NAMSW N/A
  • CCCS 7.0B
  • IPO Year
  • NAMSW N/A
  • CCCS N/A
  • Fundamental
  • Price
  • NAMSW $9.00
  • CCCS $11.17
  • Analyst Decision
  • NAMSW
  • CCCS Buy
  • Analyst Count
  • NAMSW 0
  • CCCS 7
  • Target Price
  • NAMSW N/A
  • CCCS $13.71
  • AVG Volume (30 Days)
  • NAMSW N/A
  • CCCS 5.2M
  • Earning Date
  • NAMSW N/A
  • CCCS 07-30-2024
  • Dividend Yield
  • NAMSW N/A
  • CCCS N/A
  • EPS Growth
  • NAMSW N/A
  • CCCS N/A
  • EPS
  • NAMSW N/A
  • CCCS N/A
  • Revenue
  • NAMSW N/A
  • CCCS $888,695,000.00
  • Revenue This Year
  • NAMSW N/A
  • CCCS $11.62
  • Revenue Next Year
  • NAMSW N/A
  • CCCS $8.89
  • P/E Ratio
  • NAMSW N/A
  • CCCS N/A
  • Revenue Growth
  • NAMSW N/A
  • CCCS 11.01
  • 52 Week Low
  • NAMSW N/A
  • CCCS $10.32
  • 52 Week High
  • NAMSW N/A
  • CCCS $13.41
  • Technical
  • Relative Strength Index (RSI)
  • NAMSW 47.49
  • CCCS 52.93
  • Support Level
  • NAMSW $9.40
  • CCCS $11.15
  • Resistance Level
  • NAMSW $10.14
  • CCCS $11.51
  • Average True Range (ATR)
  • NAMSW 0.44
  • CCCS 0.19
  • MACD
  • NAMSW -0.12
  • CCCS 0.02
  • Stochastic Oscillator
  • NAMSW 24.31
  • CCCS 73.44

About NAMSW NewAmsterdam Pharma Company N.V. Warrant

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About CCCS CCC Intelligent Solutions Holdings Inc.

CCC Intelligent Solutions Holdings Inc is a provider of cloud, mobile, AI, telematics, hyperscale technologies and applications for the property and casualty insurance economy. The company's SaaS platform connects trading partners, facilitates commerce, and supports mission-critical, and AI-enabled digital workflows. The company generate revenue through the sale of software subscriptions and other revenue, primarily from professional services. The company has its presence in United States and China. Majority of the revenue is generated from United States.

Share on Social Networks: